tm logo
PB PHASEBIO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 16 Oct 2023

Last Applicant/ Owned by

1 Great Valley Parkway, Suite 30

Malvern

PA

19355

Serial Number

88847647 filed on 25th Mar 2020

Registration Number

N/A

Correspondent Address

Brendan J. Hughes

Brendan J. Hughes

1299 PENNSYLVANIA AVENUE, NW, SUITE 700

WASHINGTON DC 20004

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

PB PHASEBIO

Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of pharmaceuticals Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations for treating orphan diseases, namely, cystic fibrosis, Duchenne Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of pharmaceuticals

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations for treating orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceuticals comprising drugs based on recombinant Elastin-like polypeptides technology platform, namely, pharmaceuticals for treating heart disease, heart conditions, hypertension, pulmonary hypertension, other disorders of the cardiopulmonary system, and orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors

Mark Details


Serial Number

No 88847647

Mark Type

No Service Mark

Attorney Docket Number

No 309646-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.11.12 -

Hearts depicted on playing cards

27.01.04 -

Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps

Legal History


Show more

Status DateAction Taken
16th Oct 2023ABANDONMENT - NO USE STATEMENT FILED
16th Oct 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
23rd Mar 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Mar 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
22nd Mar 2023SOU EXTENSION 5 GRANTED
10th Mar 2023SOU TEAS EXTENSION RECEIVED
10th Mar 2023SOU EXTENSION 5 FILED
07th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
15th Sep 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Sep 2022SOU TEAS EXTENSION RECEIVED